Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Other Working Capital Changes (2022 - 2025)

Bioregenx (BRGX) has 4 years of Other Working Capital Changes data on record, last reported at -$29400.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 154.75% year-over-year to -$29400.0; the TTM value through Sep 2025 reached -$153867.0, up 46.25%, while the annual FY2024 figure was -$134976.0, 67.42% down from the prior year.
  • Other Working Capital Changes reached -$29400.0 in Q3 2025 per BRGX's latest filing, up from -$64108.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $104554.0 in Q1 2023 and bottomed at -$203877.0 in Q4 2023.
  • Average Other Working Capital Changes over 4 years is -$21123.5, with a median of -$2667.0 recorded in 2022.
  • The widest YoY moves for Other Working Capital Changes: up 2784.7% in 2023, down 7544.43% in 2023.
  • A 4-year view of Other Working Capital Changes shows it stood at -$2667.0 in 2022, then crashed by 7544.43% to -$203877.0 in 2023, then soared by 74.19% to -$52614.0 in 2024, then soared by 44.12% to -$29400.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$29400.0 in Q3 2025, -$64108.0 in Q2 2025, and -$7745.0 in Q1 2025.